Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
This study is ongoing, but not recruiting participants.
Study NCT00004067
Information provided by National Surgical Adjuvant Breast and Bowel Project (NSABP)
First Received: December 10, 1999
Last Updated: August 7, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
